These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 10796314)
21. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. Segal JB; McNamara RL; Miller MR; Powe NR; Goodman SN; Robinson KA; Bass EB Cochrane Database Syst Rev; 2001; (1):CD001938. PubMed ID: 11279741 [TBL] [Abstract][Full Text] [Related]
22. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. ; Connolly SJ; Pogue J; Hart RG; Hohnloser SH; Pfeffer M; Chrolavicius S; Yusuf S N Engl J Med; 2009 May; 360(20):2066-78. PubMed ID: 19336502 [TBL] [Abstract][Full Text] [Related]
23. Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial. Hankey GJ; Eikelboom JW; Yi Q; Lees KR; Chen C; Xavier D; Navarro JC; Ranawaka UK; Uddin W; Ricci S; Gommans J; Schmidt R; Lancet Neurol; 2012 Jun; 11(6):512-20. PubMed ID: 22554931 [TBL] [Abstract][Full Text] [Related]
24. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Benavente O; Hart R; Koudstaal P; Laupacis A; McBride R Cochrane Database Syst Rev; 2000; (2):CD001927. PubMed ID: 10796453 [TBL] [Abstract][Full Text] [Related]
25. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. De Schryver EL; Algra A; van Gijn J Cochrane Database Syst Rev; 2007 Jul; (3):CD001820. PubMed ID: 17636684 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322 [TBL] [Abstract][Full Text] [Related]
27. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418 [TBL] [Abstract][Full Text] [Related]
28. Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation. Cooper NJ; Sutton AJ; Lu G; Khunti K Arch Intern Med; 2006 Jun; 166(12):1269-75. PubMed ID: 16801509 [TBL] [Abstract][Full Text] [Related]
29. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin. Algra A; De Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ Cochrane Database Syst Rev; 2006 Jul; (3):CD001342. PubMed ID: 16855967 [TBL] [Abstract][Full Text] [Related]
30. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox KM; Hennerici MG; Mattle HP; Rothwell PM; de Cordoüe A; Fratacci MD; Lancet; 2011 Jun; 377(9782):2013-22. PubMed ID: 21616527 [TBL] [Abstract][Full Text] [Related]
31. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. De Schryver EL; Algra A; van Gijn J Cochrane Database Syst Rev; 2006 Apr; (2):CD001820. PubMed ID: 16625549 [TBL] [Abstract][Full Text] [Related]
32. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial. ; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798 [TBL] [Abstract][Full Text] [Related]
33. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Diener HC; Bogousslavsky J; Brass LM; Cimminiello C; Csiba L; Kaste M; Leys D; Matias-Guiu J; Rupprecht HJ; Lancet; 2004 Jul 24-30; 364(9431):331-7. PubMed ID: 15276392 [TBL] [Abstract][Full Text] [Related]